✦ LIBER ✦

Bioavailability and tolerability of mebendazole in patients with inoperable hydatid disease

✍ Scribed by A.D.M. Bryceson; R. Woestenborghs; M. Michiels; H. Van Den Bossche

Publisher: Elsevier Science
Year: 1982
Tongue: English
Weight: 130 KB
Volume: 76
Category: Article
ISSN: 0035-9203
DOI: 10.1016/0035-9203(82)90163-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy, tolerability, and safety of ri

Efficacy, tolerability, and safety of risedronate in Japanese patients with Paget’s disease of bone

✍ Kousei Yoh; Shinjiro Takata; Noriko Yoshimura; Jun Hashimoto 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 360 KB

Immunodiagnosis of pulmonary hydatid dis

Immunodiagnosis of pulmonary hydatid disease in a patient with negative radiologic and scintillographic findings

✍ E.A. Guarnera; V.M. Varela-Díaz 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 241 KB

Bioavailability of metronidazole in fast

Bioavailability of metronidazole in fasting and non-fasting healthy subjects and in patients with Crohn's disease

✍ A. Melander; G. Kahlmeter; C. Kamme; B. Ursing 📂 Article 📅 1977 🏛 Springer 🌐 English ⚖ 363 KB

Effectiveness and tolerability of repeat

Effectiveness and tolerability of repeated treatment with infliximab in patients with Crohn’s disease: a retrospective data analysis in Germany

✍ Thomas Witthöft; Diether Ludwig 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 167 KB

Pharmacokinetics, safety, and tolerabili

Pharmacokinetics, safety, and tolerability of flosequinan in patients with hepatic dysfunction

✍ J. L. Hinson; I. D. Hind; D. J. Weidler 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

Tolerability of switching from donepezil

Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease

✍ Gunhild Waldemar; Maritta Hyvärinen; Mette Krog Josiassen; Alex Kørner; Heikki L 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 44 KB 👁 2 views

This study investigates the tolerability, safety and efficacy of abrupt or stepwise switching from donepezil to memantine treatment in patients with moderate-to-severe Alzheimer's disease (AD). Outpatients (Table 1), !50 years, with dementia of the Alzheimer's type (DSM-IV-TR), MMSE 18 and receiving